Purple steroid inhaler side effects

The replacement of a systemic corticosteroid with a
topical corticosteroid can be accompanied by signs of adrenal insufficiency. In
addition, some patients may experience symptoms of corticosteroid withdrawal,
., joint and muscular pain, lassitude , and depression. Patients previously
treated for prolonged periods with systemic corticosteroids and transferred to
topical corticosteroids should be carefully monitored for acute adrenal
insufficiency in response to stress . In those patients who have asthma or other
clinical conditions requiring long-term systemic corticosteroid treatment,
rapid decreases in systemic corticosteroid dosages may cause a severe
exacerbation of their symptoms.

Decreases in bone mineral density (BMD) have been
observed with long-term administration of products containing inhaled
corticosteroids, including flunisolide. The clinical significance of small
changes in BMD with regard to long-term outcomes is unknown. Monitor patients
with major risk factors for decreased bone mineral content, such as prolonged
immobilization, family history of osteoporosis , postmenopausal status, tobacco
use, advanced age, poor nutrition, or chronic use of drugs that can reduce bone
mass (., anticonvulsants and corticosteroids) and treat with established
standards of care.